The intestinal microbial metabolite acetyl l-carnitine improves gut inflammation and immune homeostasis via CADM2
Authors:
Open Access
- 16 February 2024
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1870 (4) , 167089
Abstract
No abstract availableKeywords
Funding Information
- National Clinical Key Specialty Project Foundation
This publication has 62 references indexed in Scilit:
- Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg/Th17 cell balance and intestinal barrier integrityBiomedicine & Pharmacotherapy, 2023
- The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose–response meta-analysisInflammopharmacology, 2023
- Cross‐talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implicationsIUBMB Life, 2015
- An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel DiseasesCell Host & Microbe, 2015
- The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolismSeminars in Immunopathology, 2014
- Role of the Microbiota in Immunity and InflammationCell, 2014
- The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseCell Host & Microbe, 2014
- Microbiota in autoimmunity and toleranceCurrent Opinion in Immunology, 2011
- Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2α (8-iso-PGF2α) level in patients with inflammatory bowel diseasesInflammatory Bowel Diseases, 2010
- Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human IntestineCell, 2006